Original Investigation

The Evaluation of Metabolic Syndrome Parameters of Patients with Hashimoto’s Thyroiditis

10.5152/imj.2015.50251

  • Sevil Özkan
  • Kadir Kayataş

Received Date: 10.09.2015 Accepted Date: 21.10.2015 İstanbul Med J 2015;16(4):141-144

Objective:

In this study, we aimed to investigate the relationship between the prevalence of metabolic syndrome (MS) and the relationship between MS parameters in patients diagnosed with Hashimoto’s thyroiditis (HT).

Methods:

A total of 100 patients admitted to the internal medicine clinic between July and March 2013 and diagnosed with HT were included in this study. Age, gender, height, weight, waist circumference, arterial blood pressure, fasting blood glucose, HDL cholesterol, and triglyceride levels were recorded. Patients were evaluated according to the diagnostic criteria of the MS in the National Cholesterol Education Program - Adult Treatment Panel III (NCEP- ATP III) - 2001.

Results:

The ages of HT patients included in the study ranged from 19 to 67 years, with an average of 45.00±12.20 years; 90% of patients were females. According to the NCEP-ATP III diagnostic criteria, MS was observed in 30% of patients (n=30). We observed abdominal obesity in 73.3% of the patients (n=22), hyperglycemia in 73.3% (n=22), hypertriglyceridemia in 60% (n=18), hypertension in 46.7% (n=14), and low high-density lipoprotein cholesterol (HDL-K) in 86.7% of the patients diagnosed with MS (n=26). We also noted a statistically significant difference between thyroid stimulating hormone (TSH) levels of patients and the presence of MS (p<0.01). TSH levels were higher than normal levels in patients with MS.

Conclusion:

Various parameters of MS are frequent among patients with HT, and ideal level of MS parameters should be aimed during the treatment.

Keywords: Hashimoto’s thyroiditis, metabolic syndrome, thyroid stimulating hormone